Index · Artikel · Key information missing from U.S. drug labels

Key information missing from U.S. drug labels

2009-10-22 7
   
Advertisement
résuméBOSTON Drug labels in the United States often omit information showing the severity of side effects or that a medicine is not very effective, two doctors said Wednesday. The result can be a document skewed toward making a medicine seem safer and more
Advertisement

Key information missing from U.S. drug labels


BOSTON Drug labels in the United States often omit information showing the severity of side effects or that a medicine is not very effective, two doctors said Wednesday.

The result can be a document skewed toward making a medicine seem safer and more effective than it really is, they wrote in a commentary in the New England Journal of Medicine.

"Much critical information that the Food and Drug Administration has at the time of approval may fail to make its way into the drug label and relevant journal articles," wrote Drs. Lisa Schwartz and Steven Woloshin of the Dartmouth Institute for Health Policy and Clinical Practice in Hanover, New Hampshire.

The labels are written by the manufacturers and the wording is negotiated with the FDA, which gives final approval.

But key information can be missing, Woloshin said in a telephone interview. "How can I decide if the potential harms of this drug are worth the risk if I don't know how well the drug works, and vice versa?" he asked.

One example is Sepracor's four-year-old sleep drug Lunesta, promoted with an advertising campaign that cost $750,000 a day in 2007.

The company generated sales of $600 million last year and became a wholly-owned subsidiary of Dainippon Sumitomoto Pharma Co Tuesday.

The label says, without specifics, that Lunesta was superior to a placebo.

But test results submitted to the FDA showed that in the largest and longest study, "Lunesta patients still met criteria for insomnia and reported no clinically meaningful improvements in next-day alertness or functioning," Schwartz and Woloshin wrote.

Sepracor responded that more detailed information about its products, beyond what the FDA wants, is always available to healthcare providers who ask for it, including from the company's scientific staff.

NO IMPROVEMENTS

A similar example is Takeda Pharmaceutical Co's insomnia drug Rozerem. Its label omitted laboratory data showing it still took 31 minutes, for adults over age 64, and 24 minutes for younger adults to fall asleep once they took the drug, compared with 38 minutes with a placebo.

In addition, volunteers reported "no subjective improvements in total sleep time, sleep quality, or the time it took to fall asleep," the researchers said. Those data were also omitted from the label.

"Sometimes what gets lost is data on harms," said Schwartz and Woloshin in their commentary. Novartis' Zometa, used for cancer patients, had a warning label noting the 8- milligram dose posed a greater risk of kidney damage. But the degree of risk was not explained.

While 19 percent of the people taking the 4-milligram dose died during the study and 19 percent died taking a comparison drug, 33 percent died when given the 8-milligram dose of Zometa.

Seven years passed before the label was changed to explicitly tell doctors not to use the higher dose, but no details were given.

Novartis and Takeda had no immediate comment.

Woloshin said he and his colleagues had come up with a better format to make the scope of the risks and benefits clearer to consumers.

Last year, the FDA's Risk Advisory Committee voted unanimously to endorse it, he said. They are scheduled to meet with the agency on the issue again next month.

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated

  • Cadbury: A Tale of Two Chocolates

    Cadbury: A Tale of Two Chocolates
    Foto von Jerine / FlickrCC Als ich in England aufwuchs war während der letzten Stadien des Zweiten Weltkriegs, sehr wenig Schokolade auf die durchschnittliche Person. Wie alle Süßigkeiten, mit Ausnahme von Bullaugen Pfefferminze Saugern wurde rationi
  • Drugs protect monkeys from Ebola, U.S. study finds

    Drugs protect monkeys from Ebola, U.S. study finds
    WASHINGTON U.S. government researchers working to find ways to treat the highly deadly Ebola virus said on Sunday a new approach from AVI BioPharma Inc saved monkeys after they were infected. Two experimental treatments protected more than 60 percent
  • Self-medication of anxiety tied to later drug abuse

    Self-medication of anxiety tied to later drug abuse
    NEW YORK (Reuters Health) - People who drink or use drugs to calm down anxious nerves are at increased risk of developing full-blown substance abuse disorder down the road, Canadian researchers have found. Their study is the first to try to shed ligh
  • Noch jemand mit wirklich beängstigend Alpträume mit Viibryd?

    Es ist nur zweimal passiert ist. Ich fürchte, das irgendetwas mit den Worten zu verhexen, aber ich glaube, ich habe gerade in den Himmel ging, als ich auf Viibryd bekam. Um auf einem Anti-Depressiva und erhalten, mein Sexualtrieb halten und tatsächli
  • Prescription Geschichte und Kosten der Krankenversicherung

    Prescription Geschichte und Kosten der Krankenversicherung
    Wenn Sie für die Gesundheit oder Krankenversicherung gelten, wird es eine Reihe von Urteilen durch die Konsortialbanken verwendet werden, um zu bestimmen, wie viel sie verlangen wird bei Ihnen zu versichern. Da nach dem Gesetz können die Versicherer
  • Eine weibliche Weise, Ihre Träume zu manifestieren - Teil 1

    Eine weibliche Weise, Ihre Träume zu manifestieren - Teil 1
    Wie jeder gute Arzt, ich war schon früh in der männlichen Art und Weise indoktriniert zu betreiben, nicht nur im Operationssaal, sondern in der Welt. Die Regeln Drücken. Streben. Setzen Sie Ihren Arsch in den Stuhl, bis es fertig ist. Mach es möglich
  • Wie Depressive Menschen nutzen das Internet

    Wie Depressive Menschen nutzen das Internet
    Das Internet ist verschiedene Dinge für verschiedene Menschen: ein soziales Zentrum, gigantische Referenzbibliothek oder für einige, ein Ort, um Trost zu suchen. In der Tat zeigt die Forschung, dass die Art und Weise depressive Menschen das Internet
  • Blueprint Gesundheit der neuen Klasse zeigt, dass es immer noch viele neue Ideen in der digitalen Gesundheit Pipeline

    Blueprint Gesundheit der neuen Klasse zeigt, dass es immer noch viele neue Ideen in der digitalen Gesundheit Pipeline
    Ein anderer Tag, eine andere Klasse von digitalen Gesundheits Start-ups. Das ist, wie es sich anfühlt, manchmal mit so vielen Beschleuniger arbeiten mit Dutzenden von neuen Unternehmen pro Jahr. Zwar gibt es viele "me-too" Start-ups Eingabe über
  • Das Lab-Gewachsen Niere Halten Rats-und vielleicht sogar You-Lebend

    Das Lab-Gewachsen Niere Halten Rats-und vielleicht sogar You-Lebend
    Zum ersten Mal überhaupt ein ganzes Labor-grown Niere wurde in eine Ratte erfolgreich transplantiert , wo sie die Kreatur Urin erlaubt wie eine wirklich Niere zu verarbeiten würde-und es könnte eines Tages Ihr Leben retten. Ein Team von Forschern des
  • Thinking differently: Autism finds space in the workplace

    Thinking differently: Autism finds space in the workplace
    LONDON Some call it neurological diversity, others see it as autism's fight back. People diagnosed as "on the spectrum" are suddenly in demand by employers seeking a competitive advantage from autistic workers more used to being considered disab